Head-to-head comparison
Harbor vs Queen RX
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.
From $99/mo (lowest dose rung) sema · From $149/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
Desk Score
Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).
$100/mo (quarterly prepay) sema · Verified July 2026
Marked down on: No LegitScript or PCAB accreditation
Queen RX takes this head-to-head with the higher Desk Score, 74/100 (C) against 65/100 (C) for Harbor. Harbor still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Harbor
65/100
C
Queen RX
74/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Harbor | Queen RX |
|---|---|---|
| Semaglutide | From $99/molowest dose rung$99/mo (starting dose, compounded) | $100/moquarterly prepay$100/mo (quarterly plan, compounded) |
| Tirzepatide | From $149/molowest dose rung$149/mo (starting dose, compounded) | Not listed on Queen RX's site (checked July 2026) |
| Coverage | Not listed on Harbor's site (checked July 2026) | 45 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee. | Budget-conscious patients seeking low-cost compounded GLP-1. |
| Desk Score | 65/100C | 74/100C |
The verdict
Desk pick — Queen RXQueen RX takes this head-to-head with the higher Desk Score, 74/100 (C) against 65/100 (C) for Harbor. Harbor still holds its ground where its strengths line up with yours.
Choose Harbor if…
Adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee.
From $99/mo (lowest dose rung) sema · From $149/mo (lowest dose rung) tirz
Choose Queen RX if…
Budget-conscious patients seeking low-cost compounded GLP-1.
$100/mo (quarterly prepay) sema · 45 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Harbor · Queen RX.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Harbor
- CoreAge Rx vs Queen RX
- Harbor vs Sunlight
- Queen RX vs Sunlight
- Harbor vs Invigor Medical
- NewSelf vs Queen RX
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.